The Birmingham Health Innovation Campus will align with the broader life sciences expertise and infrastructure across the West Midlands and help establish Birmingham as a leading economic hub for life sciences.

There are already 22,000 people employed in the sector across the region and more than 600 companies working in this area. The development of the park will afford industry greater access to leading research and facilities, investment prospects and the opportunity to develop their own facility spaces. This will give our local enterprises the edge in a competitive sector and promote job creation.

Our vision, along with our partners Bruntwood SciTech,  is to attract the establishment of new SMEs and investment from large pharma and biotechnology firms. This will further enhance the region’s status as an internationally recognised hub for clinical academia. 

BHIC will:

• Offer precision medicine using personalised approaches to trial design for developing and testing new treatments and technologies.
• Use integrated data to drive improvements in healthcare through a greater understanding of the causes and potential treatments of disease.
• Train the workforce of the future to deliver multidisciplinary research and healthcare.

Businesses located at the site will also benefit from access to Bruntwood SciTech’s specialist business support and partner network, enabling them to grow at pace and scale with access to finance, talent and new markets. 

This will be a pioneering and globally significant location that brings together outstanding researchers, clinicians, policy makers and industry to rapidly translate scientific and clinical insights into patient benefit and economic growth. It will reinforce Birmingham’s global role, supporting innovative new partnerships and leveraging strong existing collaborations. Working with and for our large, diverse regional patient and public communities, it will be unparalleled in its ability to co-create dynamic solutions to some of the biggest challenges in life sciences and healthcare. It will benefit from outstanding clinical data integration and analytics, real world evidence and patient engagement.

This signature facility is the focal point of the BHIC development, providing 6,000 sq m of innovation, co-creation and incubation space.

The Precision Health Technologies Accelerator (PHTA) is dedicated to the rapid development and translation of innovative therapies and technologies from concept to clinical evaluation by creating new opportunities for businesses and entrepreneurs to innovate and grow, and for clinical-academics in the region to commercialise their ideas.

The PHTA builds on BHP’s nationally-recognised strengths and will support businesses through access to expertise in: 

• the development and delivery of complex clinical trials
• complex diagnostics, multi-omics analysis and heath data
• medtech design and development

PHTA provides early incubation, grow-on space and innovation services for businesses working across biopharma, advanced therapies, diagnostics, digital health and healthcare technologies. Its incubation services for early-stage businesses include Category 2 wet and dry lab-office modules of between 600-1,200 sq ft, an advanced medtech Makerspace prototyping facility, flexible workspaces and a substantial training suite. 

Will there be space on the Birmingham Health Innovation Campus for companies to locate?

Yes. The park will be comprised of research and development and service facilities including office spaces, laboratories and co-creation/co-development spaces. Please contact Bruntwood SciTech for more information. 

What are the timelines for the development?

Outline planning permission for the full 10-acre masterplan has been granted and the first phase of the development, No.1 BHIC, opened its doors in 2025. Subsequent phases of development will be completed over the next decade. 

What are the main benefits of locating on BHIC?

The location of BHIC at the confluence of the University of Birmingham campus, University Hospitals Birmingham and Birmingham Women’s and Children’s NHS Foundation Trusts will facilitate unrivalled access to the infrastructure of BHP, as well as Bruntwood SciTech’s specialist business support and innovation services.

This will be a pioneering site that brings together outstanding researchers, clinicians, policy makers and industry to rapidly translate scientific and clinical insights into patient benefit and economic growth. It will reinforce Birmingham’s ability to support innovative new partnerships and leverage strong existing collaborations. All these factors make BHIC an exciting proposition as part of the evolution of life sciences in not only Birmingham but the wider region and UK.

For details regarding office and lab space and to make an enquiry, please contact Bruntwood SciTech directly at hello.scitech@bruntwood.co.uk.